Vasogen-- VAS on TSE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Vasogen-- VAS on TSE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DewDiligence_on_SI who wrote (338)	8/31/2005 7:09:40 PM
From: Pluvia	Read Replies (1) of 377

Celacade bombs in PAD: yes interesting. we believe it bombed for the reason we suggested earlier - the VSGN dose is too small to treat PAD Message 21568901 "chf is an interesting market. that said, most researchers note the vsgn chf and paod trials failed to use a number of commonly avaialble diagnostics that would have better evidenced results, or lack of results. i think vsgn did this on purpose as using the better diagnostics would have demonstrated very marginal results. vsgn's problem is 10cc's is not a big enough dose. others can produce a bigger dose... which is just one reason i think vsgn gets leapfrogged..."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next